Jiarong Yi
The State Key Laboratory Of Oncology In South China
Guangzhou, China
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
The Prediction Model for Triple-Negative Breast Cancer Prognosis and Immunotherapy Efficacy Based on Single-Cell Sequencing of CD8+ T cells.
Journal: Journal of Cancer
Published: April 10, 2025
Disitamab Vedotin in HER2-Positive and HER2-Low Breast Cancer: A Multicenter Retrospective Analysis.
Disitamab Vedotin in HER2-Positive and HER2-Low Breast Cancer: A Multicenter Retrospective Analysis.
Journal: Oncology research
Published: March 01, 2025
Model for predicting immunotherapy based on M2 macrophage infiltration in TNBC.
Journal: Frontiers in immunology
Published: January 26, 2023
Prognostic value of comprehensive typing based on m6A and gene cluster in TNBC.
Journal: Journal of cancer research and clinical oncology
Published: August 02, 2022
Androgen receptor expression and its prognostic value in T1N0 luminal/HER2- breast cancer.
Journal: Future oncology (London, England)
Published: March 01, 2022
A Prognostic Model for Breast Cancer Based on Cancer Incidence-Related DNA Methylation Pattern.
Journal: Frontiers in genetics
Published: November 13, 2021
Peripheral blood lymphocytes subtypes as new predictors for neoadjuvant therapy efficacy in breast cancer.
Journal: Cancer medicine
Published: September 21, 2021
Nomogram to Predict Tumor-Infiltrating Lymphocytes in Breast Cancer Patients.
Journal: Frontiers in molecular biosciences
Published: August 19, 2021
Identification of Immune-Related Risk Characteristics and Prognostic Value of Immunophenotyping in TNBC.
Journal: Frontiers in genetics
Published: June 24, 2021
Showing 1-11 of 11
Last Updated: 09/26/2026